Johnson & Johnson
(NYSE:JNJ)
$
265.99
+6.66 (+2.57%)
Market Cap: 640.28 Bil
Enterprise Value: 673.22 Bil
PE Ratio: 30.75
PB Ratio: 7.88
GF Score: 81/100 Johnson & Johnson at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 10, 2021 / 04:20PM GMT
Release Date Price:
$164.27
(+1.08%)
Matthew Stephan Miksic;dit Suisse AG
CrÃ;Research Division - Senior Research Analyst
© -
Okay. So I think we're back. Thanks, everyone, for joining us. Sorry for the late start here. We had a little -- a few technical issues getting everyone together, but we're here now. My name is Matt Miksic. I cover medical devices here at Credit Suisse. And I'm very pleased to have with us today, Ashley McEvoy, Executive Vice President, World Chair of J&J's Medical Device business. Ashley, thanks so much for taking the time to join us.
Ashley A. McEvoy
Johnson & Johnson - Executive VP & Worldwide Chairman of Medical Devices
Yes, it's a pleasure to be here, Matt. Thanks for having me.
Questions & Answers
Matthew Stephan Miksic;dit Suisse AG
CrÃ;Research Division - Senior Research Analyst
© -
Pleasure is all ours. So I thought it might be a reasonable place to start. It seems like where every conversation starts this quarter is just around the environment.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot